共 50 条
- [31] HIV-1 isolates resistant to CCR5 antagonists demonstrate increased affinity for the drug-bound coreceptorANTIVIRAL THERAPY, 2007, 12 (05) : S135 - S135Buontempo, P. J.Wojcik, L.Buontempo, C.Strizki, J.Ralston, R.
- [32] HIV-1 isolates resistant to CCR5 antagonists demonstrate increased affinity for the drug-bound coreceptorANTIVIRAL THERAPY, 2007, 12 : S135 - S135Buontempo, P. J.Wojcik, L.Buontempo, C.Strizki, J.Ralston, R.
- [33] Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 StrainsANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2369 - 2378Schanzer, JuergenJekle, AndreasNezu, JunichiLochner, AdrianeCroasdale, RebeccaDioszegi, MariannaZhang, JunHoffmann, EikeDormeyer, WilmaStracke, JanSchaefer, WolfgangJi, ChanghuaHeilek, GabrielleCammack, NickBrandt, MichaelUmana, PabloBrinkmann, Ulrich
- [34] Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cellsNATURE MEDICINE, 2002, 8 (02) : 150 - 156Meng, GWei, XPWu, XYSellers, MTDecker, JMMoldoveanu, ZOrenstein, JMGraham, MFKappes, JCMestecky, JShaw, GMSmith, PD
- [35] Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cellsNature Medicine, 2002, 8 : 150 - 156Gang MengXiping WeiXiaoyun WuMarty T. SellersJulie M. DeckerZina MoldoveanuJan M. OrensteinMartin F. GrahamJohn C. KappesJiri MesteckyGeorge M. ShawPhillip D. Smith
- [36] R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5EMBO MOLECULAR MEDICINE, 2013, 5 (05) : 776 - 794Cavarelli, MariangelaFoglieni, ChiaraRescigno, MariaScarlatti, Gabriella
- [37] Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (51) : 36923 - 36932Monde, KazuakiMaeda, YosukeTanaka, YuetsuHarada, ShinjiYusa, Keisuke
- [38] CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitroJOURNAL OF IMMUNOLOGY, 2000, 164 (06): : 3426 - 3433Lopalco, LBarassi, CPastori, CLonghi, RBurastero, SETambussi, GMazzotta, FLazzarin, AClerici, MSiccardi, AG
- [39] R5 HIV-1 gp120 Activates p38 MAPK to Induce Rat Cardiomyocyte Injury by the CCR5 CoreceptorPATHOBIOLOGY, 2019, 86 (5-6) : 274 - 284Gao, RuiFang, QiujuanZhang, XiXu, QinYe, HanhuiGuo, WenyanHe, JiaoChen, YahongWang, RuixingWu, ZhijuanYu, Jing
- [40] Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatmentAIDS, 2007, 21 (15) : 2108 - 2110Gilliam, Bruce L.Heredia, AlonsoDeVico, AnthonyLe, NhutBamba, DoutyBryant, Joseph L.Pauza, C. DavidRedfield, Robert R.